(Q39793584)

14 September 2017

title

Vorinostat inhibits brain metastatic colonization in a model of triple-negative breast cancer and induces DNA double-strand breaks (English)

1 reference

triple-negative breast cancer

14 September 2017

main subject

1 reference

18

1 reference

14 September 2017

28

Patricia S Steeg

1 reference

14 September 2017

Diane Palmieri

1

1 reference

14 September 2017

Paul R Lockman

2

1 reference

14 September 2017

Fancy C Thomas

3

1 reference

14 September 2017

Emily Hua

4

1 reference

14 September 2017

Jeanne Herring

5

1 reference

14 September 2017

Elizabeth Hargrave

6

1 reference

14 September 2017

Matthew Johnson

7

1 reference

14 September 2017

Natasha Flores

8

1 reference

14 September 2017

Yongzhen Qian

9

1 reference

14 September 2017

Eleazar Vega-Valle

10

1 reference

14 September 2017

Kunal S Taskar

11

1 reference

14 September 2017

Vinay Rudraraju

12

1 reference

14 September 2017

Rajendar K Mittapalli

13

1 reference

14 September 2017

Julie A Gaasch

14

1 reference

14 September 2017

Kaci A Bohn

15

1 reference

14 September 2017

Helen R Thorsheim

16

1 reference

14 September 2017

David J Liewehr

17

1 reference

14 September 2017

John F Reilly

19

1 reference

14 September 2017

Robert Walker

20

1 reference

14 September 2017

Julie L Bronder

21

1 reference

14 September 2017

Lionel Feigenbaum

22

1 reference

14 September 2017

Seth M Steinberg

23

1 reference

14 September 2017

Kevin Camphausen

24

1 reference

14 September 2017

Paul S Meltzer

25

1 reference

14 September 2017

Victoria M Richon

26

1 reference

14 September 2017

Quentin R Smith

27

1 reference

14 September 2017

language of work or name

English

0 references

publication date

29 September 2009

1 reference

14 September 2017

published in

Clinical Cancer Research

1 reference

14 September 2017

volume

15

1 reference

14 September 2017

issue

19

1 reference

14 September 2017

page(s)

6148-6157

1 reference

Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease

14 September 2017

cites work

1 reference

12 December 2020

Technique-dependent variations in cerebral microvessel blood volumes and hematocrits in the rat

1 reference

12 December 2020

Her-2 overexpression increases the metastatic outgrowth of breast cancer cells in the brain

1 reference

12 December 2020

Brain uptake of nonsteroidal anti-inflammatory drugs: ibuprofen, flurbiprofen, and indomethacin.

1 reference

12 December 2020

Vorinostat enhances the radiosensitivity of a breast cancer brain metastatic cell line grown in vitro and as intracranial xenografts

1 reference

12 December 2020

Function of yeast Rad52 protein as a mediator between replication protein A and the Rad51 recombinase

1 reference

12 December 2020

Modulation of radiation response by histone deacetylase inhibition

1 reference

12 December 2020

The blood-brain barrier and oncology: new insights into function and modulation

1 reference

12 December 2020

Distinct populations of human PCNA are required for initiation of chromosomal DNA replication and concurrent DNA repair

1 reference

12 December 2020

Effect of Herceptin on the development and progression of skeletal metastases in a xenograft model of human breast cancer

1 reference

12 December 2020

Sequence-specific potentiation of topoisomerase II inhibitors by the histone deacetylase inhibitor suberoylanilide hydroxamic acid

1 reference

12 December 2020

A phase II trial of vorinostat (suberoylanilide hydroxamic acid) in metastatic breast cancer: a California Cancer Consortium study

1 reference

12 December 2020

Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis

1 reference

12 December 2020

Suberoylanilide hydroxamic acid (SAHA) has potent anti-glioma properties in vitro, ex vivo and in vivo

1 reference

12 December 2020

The seed and soil hypothesis: vascularisation and brain metastases

1 reference

12 December 2020

Role of site-specific binding to plasma albumin in drug availability to brain

1 reference

12 December 2020

Screening of multidrug-resistance sensitive drugs by in situ brain perfusion in P-glycoprotein-deficient mice

1 reference

12 December 2020

Breast cancer metastasis to the central nervous system

1 reference

12 December 2020

Histone H2AX in DNA damage and repair.

1 reference

12 December 2020

Histone deacetylase inhibitors (HDI) cause DNA damage in leukemia cells: a mechanism for leukemia-specific HDI-dependent apoptosis?

1 reference

12 December 2020

Vorinostat, a histone deacetylase inhibitor, enhances the response of human tumor cells to ionizing radiation through prolongation of gamma-H2AX foci

1 reference

12 December 2020

Histone deacetylase inhibitor selectively induces p21WAF1 expression and gene-associated histone acetylation

1 reference

12 December 2020

Effect of lapatinib on the outgrowth of metastatic breast cancer cells to the brain

1 reference

12 December 2020

Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis

1 reference

12 December 2020

Functional interactions among yeast Rad51 recombinase, Rad52 mediator, and replication protein A in DNA strand exchange

1 reference

12 December 2020

Continuous intracranial administration of suberoylanilide hydroxamic acid (SAHA) inhibits tumor growth in an orthotopic glioma model

1 reference

12 December 2020

A phase III randomized comparison of lapatinib plus capecitabine versus capecitabine alone in women with advanced breast cancer that has progressed on trastuzumab: updated efficacy and biomarker analyses

1 reference

12 December 2020

The blood-brain barrier and cancer: transporters, treatment, and Trojan horses

1 reference

12 December 2020

CNS metastases in breast cancer

1 reference

12 December 2020

Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor: effects on gene expression and growth of glioma cells in vitro and in vivo

1 reference

12 December 2020

A cross-platform public domain PC image-analysis program for the comet assay

1 reference

12 December 2020

In vitro and in vivo histone deacetylase inhibitor therapy with suberoylanilide hydroxamic acid (SAHA) and paclitaxel in ovarian cancer

1 reference

12 December 2020

Histone deacetylase inhibitors: molecular mechanisms of action

1 reference

12 December 2020

Passive permeability and P-glycoprotein-mediated efflux differentiate central nervous system (CNS) and non-CNS marketed drugs.

1 reference

12 December 2020

Rad52 protein stimulates DNA strand exchange by Rad51 and replication protein A

1 reference

12 December 2020

Medicinal chemical properties of successful central nervous system drugs

1 reference

12 December 2020

Tight junctions of the blood-brain barrier

1 reference

12 December 2020

10.1158/1078-0432.CCR-09-1039

Identifiers

DOI

1 reference

14 September 2017

1 reference